IP Library Granted Patent US 8,070,934
Granted Patent B2
US 8,070,934 · App. 11/933,219 · Granted Dec 6, 2011

Transition metal complexes with (pyridyl)imidazole ligands

Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,070,934
App. No.
11/933,219
Granted
Dec 6, 2011
Kind
B2
Abstract

Novel transition metal complexes of iron, cobalt, ruthenium, osmium, and vanadium are described. The transition metal complexes can be used as redox mediators in enzyme-based electrochemical sensors. The transition metal complexes include substituted or unsubstituted (pyridyl)imidazole ligands. Transition metal complexes attached to polymeric backbones are also described.

Claims (64)

1. A transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkylamino;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring.

2. The transition metal complex of claim 1 , wherein R 13 is a C1 alkylamino.

3. A method for monitoring the concentration of an analyte in biological fluid, the method comprising:

applying a sample containing the analyte to an electrochemical sensor, the electrochemical sensor comprising:

a working electrode, wherein the working electrode comprises a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is C1-C2 alkylamino;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

an analyte responsive enzyme; and

 a counter electrode; and

determining the concentration of an analyte in the sample.

4. The method of claim 3 wherein the analyte is glucose.

5. The method of claim 3 wherein the analyte is a ketone.

6. A transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkoxy;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring.

7. The transition metal complex of claim 6 , wherein R 13 is a C1 alkoxy.

8. A method for monitoring the concentration of an analyte in biological fluid, the method comprising:

applying a sample containing the analyte to an electrochemical sensor, the electrochemical sensor comprising:

a working electrode, wherein the working electrode comprises a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkoxy;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —Cl, —Br, —I, —NO 2 , —CN, —CO 2 H, —SO 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

an analyte responsive enzyme; and

a counter electrode; and

determining the concentration of an analyte in the sample.

9. The method of claim 8 , wherein the analyte is glucose.

10. The method of claim 8 , wherein the analyte is a ketone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2008
From: MAO, FEI; HELLER, ADAM
To: ABBOTT DIABETES CARE INC.
Reel/Frame 020805/0309 →
Continuity (5)
Continuation In Part 11361427 · Feb 24, 2006
Continuation 10714835 · Nov 14, 2003
Continuation 10143300 · May 9, 2002
Provisional Application 60290537 · May 11, 2001
Related Publication 20080197026A1 · Aug 21, 2008